By Lauren Tanabe
Some experts view ketamine as a tool to unravel the biological causes of depression and, perhaps someday, cure it.
Read on elemental.medium.com
CLEAR ALL
When Michael Pollan set out to research how LSD and psilocybin (the active ingredient in magic mushrooms) are being used to provide relief to people suffering from difficult-to-treat conditions such as depression, addiction, and anxiety, he did not intend to write what is undoubtedly his most...
6
Paul Stamets has been studying psilocybin mushrooms since the mid 1970's. Having written 6 books, including two field guides to psilocybin mushrooms, Paul has named four new psilocybin-active mushroom species.
1
"A genuine spiritual quest. . . . Extraordinary.
When a small vial arrives in her mailbox from "Lewis Carroll," Ayelet Waldman is ready to try anything. Her depression has become intolerable, severe and unmanageable; medication has failed to make a difference.
A six-day global gathering of the international scientific community in Oakland, California to explore new research into the benefits and risks of MDMA, LSD, psilocybin, ayahuasca, ketamine, ibogaine, medical marijuana, and more.
With the F.D.A. agreeing to new trials to test MDMA (better known as Ecstasy) as a treatment for PTSD—which, if approved, could be available as a drug by 2021—Acid Test is leading the charge in an evolving conversation about psychedelic drugs.
Exploring the bright future of psychedelics, Thomas B. Roberts, Ph.D., reveals how new uses for entheogens will enrich individuals as well as society as a whole. With contributions from Charles Grob, M.D., and Roger N. Walsh, M.D., Ph.D.